Background: Pancreatic cancer is the fourth leading cause of cancer-related mortality in both genders. More than 80% of patients suffer from significant weight loss at diagnosis and over time develop severe cachexia. Early nutritional support is therefore essential. Summary: This review evaluates the different nutritional therapies, such as enteral nutrition, parenteral nutrition and special nutritional supplements, on nutritional status, quality of life and survival. Key Message: Due to the high prevalence of malnutrition and the rapid development of anorexia-cachexia-syndrome, early nutritional intervention is crucial and supported by clinical data. Practical Implications: Enteral nutrition should be preferred over parenteral nutrition. Omega-3 fatty acids and L-carnitine are promising substances for the prevention of severe cachexia, but further randomized controlled trials are needed to establish generally accepted guidelines on nutrition in pancreatic cancer.

Keywords:
Enteral nutrition, Pancreatic cancer, Parenteral nutrition, L-Carnitine, Omega-3 fatty acids
1.
Siegel RL, Miller KD, Jemal A: Cancer statistics, 2015. CA Cancer J Clin 2015;65:21254.5-29.
2.
Reissfelder C, Koch M, Büchler MW, Weitz J: Pankreaskarzinom. Chirurg 2007;78:1059-1072.
3.
Seufferlein T, Porzner M, Becker T, Budach V, Ceyhan G, Esposito I, Fietkau R, Follmann M, Friess H, Galle P, Geissler M, Glanemann M, Gress T, Heinemann V, Hohenberger W, Hopt U, Izbicki J, Klar E, Kleeff J, Kopp I, Kullmann F, Langer T, Langrehr J, Lerch M, Löhr M, Lüttges J, Lutz M, Mayerle J, Michl P, Möller P, Molls M, Münter M, Nothacker M, Oettle H, Post S, Reinacher-Schick A, Röcken C, Roeb E, Saeger H, Schmid R, Schmiegel W, Schoenberg M, Siveke J, Stuschke M, Tannapfel A, Uhl W, Unverzagt S, van Oorschot B, Vashist Y, Werner J, Yekebas E; Guidelines Programme Oncology AWMF; German Cancer Society eV; German Cancer Aid: S3-Leitlinie zum exokrinen Pankreaskarzinom. Z Gastroenterol 2013;51:1395-1440.
4.
Klapman J, Malafa MP: Early detection of pancreatic cancer: why, who, and how to screen. Cancer Control 2008;15:280-287.
5.
Ghadirian P, Liu G, Gallinger S, Schmocker B, Paradis AJ, Lal G, Brunet JS, Foulkes WD, Narod SA: Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas. Int J Cancer 2002;97:807-810.
6.
Ghadirian P, Simard A, Baillargeon J: Tobacco, alcohol, and coffee and cancer of the pancreas. A population-based, case-control study in Quebec, Canada. Cancer 1991;67:2664-2670.
7.
Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey JN, Pisters PW, Evans DB, Khan R, Chou TH, Lenzi R, Jiao L, Li D: Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol 2007;102:2696-2707.
8.
Davidson W, Ash S, Capra S, Bauer J; Cancer Cachexia Study Group: Weight stabilisation is associated with improved survival duration and quality of life in unresectable pancreatic cancer. Clin Nutr 2004;23:239-247.
9.
Ferrucci LM, Bell D, Thornton J, Black G, McCorkle R, Heimburger DC, Saif MW: Nutritional status of patients with locally advanced pancreatic cancer: a pilot study. Support Care Cancer 2011;19:1729-1734.
10.
Richter E, Denecke A, Klapdor S, Klapdor R: Parenteral nutrition support for patients with pancreatic cancer - improvement of the nutritional status and the therapeutic outcome. Anticancer Res 2012;32:2111-2118.
11.
Andersson R, Dervenis C, Haraldsen P, Leveau P: Nutritional aspects in the management of pancreatic cancer. Ann Gastroenterol 2000;13:221-224.
12.
Bye A, Jordhøy MS, Skjegstad G, Ledsaak O, Iversen PO, Hjermstad MJ: Symptoms in advanced pancreatic cancer are of importance for energy intake. Support Care Cancer 2013;21:219-227.
13.
Mueller TC, Burmeister MA, Bachmann J, Martignoni ME: Cachexia and pancreatic cancer: are there treatment options? World J Gastroenterol 2014;20:9361-9373.
14.
Ozola Zalite I, Zykus R, Francisco Gonzalez M, Saygili F, Pukitis A, Gaujoux S, Charnley RM, Lyadov V: Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review. Pancreatology 2015;15:19-24.
15.
Sharma C, Eltawil KM, Renfrew PD, Walsh MJ, Molinari M: Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. World J Gastroenterol 2011;17:867-897.
16.
Bachmann J, Ketterer K, Marsch C, Fechtner K, Krakowski-Roosen H, Büchler MW, Friess H, Martignoni ME: Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function. BMC Cancer 2009;9:255.
17.
Fearon KCH, Baracos VE: Cachexia in pancreatic cancer: new treatment options and measures of success. HPB (Oxford) 2010;12:323-324.
18.
Kyle UG, Pirlich M, Lochs H, Schuetz T, Pichard C: Increased length of hospital stay in underweight and overweight patients at hospital admission: a controlled population study. Clin Nutr 2005;24:133-142.
19.
Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Büchler MW, Friess H, Martignoni ME: Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg 2008;12:1193-1201.
20.
Klek S, Sierzega M, Szybinski P, Szczepanek K, Scislo L, Walewska E, Kulig J: The immunomodulating enteral nutrition in malnourished surgical patients - a prospective, randomized, double-blind clinical trial. Clin Nutr 2011;30:282-288.
21.
Gianotti L, Braga M, Gentilini O, Balzano G, Zerbi A, Di Carlo V: Artificial nutrition after pancreaticoduodenectomy. Pancreas 2000;21:344-351.
22.
Di Carlo V, Gianotti L, Balzano G, Zerbi A, Braga M: Complications of pancreatic surgery and the role of perioperative nutrition. Dig Surg 1999;16:320-326.
23.
Brennan MF, Pisters PW, Posner M, Quesada O, Shike M: A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy. Ann Surg 1994;220:436-441; discussion 441-444.
24.
Vashi PG, Dahlk S, Popiel B, Lammersfeld CA, Ireton-Jones C, Gupta D: A longitudinal study investigating quality of life and nutritional outcomes in advanced cancer patients receiving home parenteral nutrition. BMC Cancer 2014;14:593.
25.
Pelzer U, Arnold D, Gövercin M, Stieler J, Doerken B, Riess H, Oettle H: Parenteral nutrition support for patients with pancreatic cancer. Results of a phase II study. BMC Cancer 2010;10:86.
26.
Bauer J, Capra S, Battistutta D, Davidson W, Ash S: Compliance with nutrition prescription improves outcomes in patients with unresectable pancreatic cancer. Clin Nutr 2005;24:998-1004.
27.
Wigmore SJ, Barber MD, Ross JA, Tisdale MJ, Fearon KC: Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer 2000;36:177-184.
28.
Fearon KC, Von Meyenfeldt MF, Moses AG, Van Geenen R, Roy A, Gouma DJ, Giacosa A, Van Gossum A, Bauer J, Barber MD, Aaronson NK, Voss AC, Tisdale MJ: Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 2003;52:1479-1486.
29.
Barber MD, Ross JA, Voss AC, Tisdale MJ, Fearon KC: The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer 1999;81:80-86.
30.
Barber MD, Fearon KC, Tisdale MJ, McMillan DC, Ross JA: Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia. Nutr Cancer 2001;40:118-124.
31.
Barber MD, McMillan DC, Preston T, Ross J, Fearon KC: Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. Clin Sci (Lond) 2000;98:389-399.
32.
Heller AR, Rössel T, Gottschlich B, Tiebel O, Menschikowski M, Litz RJ, Zimmermann T, Koch T: Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int J Cancer 2004;111:611-616.
33.
Arshad A, Isherwood J, Mann C, Cooke J, Pollard C, Runau F, Morgan B, Steward W, Metcalfe M, Dennison A: Intravenous ω-3 fatty acids plus gemcitabine: potential to improve response and quality of life in advanced pancreatic cancer. JPEN J Parenter Enteral Nutr 2015, Epub ahead of print.
34.
Kraft M, Kraft K, Gärtner S, Mayerle J, Simon P, Weber E, Schütte K, Stieler J, Koula-Jenik H, Holzhauer P, Gröber U, Engel G, Müller C, Feng YS, Aghdassi A, Nitsche C, Malfertheiner P, Patrzyk M, Kohlmann T, Lerch MM: L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial. Nutr J 2012;11:52.
35.
Park JS, Chung HK, Hwang HK, Kim JK, Yoon DS: Postoperative nutritional effects of early enteral feeding compared with total parental nutrition in pancreaticoduodenectomy patients: a prospective, randomized study. J Korean Med Sci 2012;27:261-267.
36.
Nagata S, Fukuzawa K, Iwashita Y, Kabashima A, Kinoshita T, Wakasugi K, Maehara Y: Comparison of enteral nutrition with combined enteral and parenteral nutrition in post-pancreaticoduodenectomy patients: a pilot study. Nutr J 2009;8:24.
37.
Liu C, Du Z, Lou C, Wu C, Yuan Q, Wang J, Shu G, Wang Y: Enteral nutrition is superior to total parenteral nutrition for pancreatic cancer patients who underwent pancreaticoduodenectomy. Asia Pac J Clin Nutr 2011;20:154-160.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.